InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: cjgaddy post# 202929

Tuesday, 02/10/2015 9:05:00 PM

Tuesday, February 10, 2015 9:05:00 PM

Post# of 346050
Nice post CJ. Everyone take their time and read this post again and pay close attention. I like the paragraph with Joe Shan quotes agreeing with Adam Yopp.

Lots and lots and lots of data building up...

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News